Search results
Drugmakers in Medicare negotiations spent more on shareholder payments and marketing than R&D last...
The Hill· 6 days agoA new report from the center-left watchdog group Accountable US found that most major drugmakers...
Zacks.com featured highlights Medpace, American Axle, Diebold Nixdorf, Euronet and Omnicom
Zacks via Yahoo Finance· 3 hours agoGet the rest of the stocks on the list and start putting this and other ideas to the test. It can...
Warren Buffett Stocks: What's Inside Berkshire Hathaway's Portfolio?
Investor's Business Daily· 16 hours agoDuring the previous two years, Berkshire Hathaway dumped severaldrug and biotech stocks, not long...
Samsung Biologics poised for growth pending BIOSECURE bill approval in US
BioPharma-Reporter· 7 days agoAccording to GlobalData, South Korean CDMO Samsung Biologics is poised to see huge growth...
Health Care Roundup: Market Talk
The Wall Street Journal· 15 hours agoThe bank reiterates its buy rating and DKK1,025...
The Zacks Analyst Blog Highlights Amgen, Amazon.com, Apple, Boeing and Goldman Sachs
Zacks via Yahoo Finance· 1 day agoFurther, the index appears unaffected compared with the other two major indices, which cooled down...
Dow Jones Rises To Extend Win Streak; Nvidia Stock Reverses Lower Despite Buy Rating
Investor's Business Daily· 22 hours agoShares gained 0.2% on the stock market today. Meanwhile, drug giant Merck is building a flat base...
Cancer Drug Price-Cutting Pitch Mulled by HHS as Industry Waits
Bloomberg Law· 4 days agoThe Biden administration is weighing a drug pricing control proposition that attorneys and industry watchers say could bolster efforts to lower prescription costs even if ...
Why Iovance Stock Is Down 18% Today
Motley Fool via Yahoo Finance· 4 days agoBut, it's ultimately a buying opportunity for interested newcomers. See, Amtagvi isn't just a promising drug. It's the first tumor-infiltrating...
Pot-Focused Finance Company Reports Higher Investment Income, Projects 'Increase In Cannabis Capital...
Benzinga· 4 days ago"It was recently reported that the U.S. Drug Enforcement Administration is moving to reclassify...